362 related articles for article (PubMed ID: 25134188)
1. Gender and geographic differences in CAD risk factors and CHADS2 scores in atrial fibrillation patients.
Bhardwaj R; Sharma P; Finkel MS; Jain S; Arham A; Kazmi T; Beto RJ; Gharib W; Warden BE; Jain AC
W V Med J; 2012; 108(1):18-21. PubMed ID: 25134188
[TBL] [Abstract][Full Text] [Related]
2. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
[TBL] [Abstract][Full Text] [Related]
3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
4. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
Rietbrock S; Heeley E; Plumb J; van Staa T
Am Heart J; 2008 Jul; 156(1):57-64. PubMed ID: 18585497
[TBL] [Abstract][Full Text] [Related]
5. Body mass index and adverse events in patients with incident atrial fibrillation.
Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
[TBL] [Abstract][Full Text] [Related]
6. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation.
Suzuki S; Sagara K; Otsuka T; Kano H; Matsuno S; Takai H; Uejima T; Oikawa Y; Koike A; Nagashima K; Kirigaya H; Yajima J; Tanabe H; Sawada H; Aizawa T; Yamashita T
Am J Cardiol; 2013 Jun; 111(11):1602-7. PubMed ID: 23499279
[TBL] [Abstract][Full Text] [Related]
8. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study).
Azarbal F; Welles CC; Wong JM; Whooley MA; Schiller NB; Turakhia MP
Am J Cardiol; 2014 Apr; 113(7):1166-72. PubMed ID: 24507169
[TBL] [Abstract][Full Text] [Related]
9. CHADS2 score predicts functional outcome of stroke in patients with a history of coronary artery disease.
Hoshino T; Ishizuka K; Shimizu S; Uchiyama S
J Neurol Sci; 2013 Aug; 331(1-2):57-60. PubMed ID: 23714421
[TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic peptide in acute ischemic stroke.
Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of CHADS
Zhou X; Cao K; Kou S; Qu S; Li H; Yu Y; Wang C; Liu Y; Li P; Li D
Int J Cardiol; 2017 Feb; 228():906-911. PubMed ID: 27912198
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of unknown atrial fibrillation in patients with risk factors.
Samol A; Masin M; Gellner R; Otte B; Pavenstädt HJ; Ringelstein EB; Reinecke H; Waltenberger J; Kirchhof P
Europace; 2013 May; 15(5):657-62. PubMed ID: 23258819
[TBL] [Abstract][Full Text] [Related]
14. The association between asymptomatic coronary artery disease and CHADS2 and CHA2 DS2 -VASc scores in patients with stroke.
Cha MJ; Lee HS; Kim YD; Nam HS; Heo JH
Eur J Neurol; 2013 Sep; 20(9):1256-63. PubMed ID: 23560528
[TBL] [Abstract][Full Text] [Related]
15. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery.
Chua SK; Shyu KG; Lu MJ; Lien LM; Lin CH; Chao HH; Lo HM
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):919-926.e1. PubMed ID: 23628495
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
[TBL] [Abstract][Full Text] [Related]
18. Prediction of coronary artery disease severity using CHADS2 and CHA2DS2-VASc scores and a newly defined CHA2DS2-VASc-HS score.
Cetin M; Cakici M; Zencir C; Tasolar H; Baysal E; Balli M; Akturk E
Am J Cardiol; 2014 Mar; 113(6):950-6. PubMed ID: 24444782
[TBL] [Abstract][Full Text] [Related]
19. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
[TBL] [Abstract][Full Text] [Related]
20. Stroke Risk Stratification With the CHADS
Obayashi Y; Shiomi H; Morimoto T; Tamaki Y; Inoko M; Nishikawa R; Kaneda K; Yamamoto K; Takeji Y; Komasa A; Yamaji K; Shizuta S; Tada T; Nagao K; Suwa S; Tamura T; Sakamoto H; Inada T; Matsuda M; Sato Y; Furukawa Y; Ando K; Kadota K; Nakagawa Y; Kimura T;
Am J Cardiol; 2022 Oct; 181():9-17. PubMed ID: 35973833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
